Concentration-dependency of β-lactam-induced filament formation in Gram-negative bacteria

Clinical Microbiology and Infection

Volumn 14, Issue 4, 2008, Pages 344-349

  Buijs, J ^a,b   Dofferhoff, A S M ^a,c   Mouton, J W ^a   Wagenvoort, J H T ^a   Van Der Meer, J W M ^d  

^a Department of Medical Microbiology and Infectious Diseases ^*  (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acinetobacter spp.; Cefotaxime; Ceftazidime; Enterobacteriaceae; Filament production; Pseudomonas aeruginosa

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE;

ACINETOBACTER; ARTICLE; BACTERIAL CELL; BACTERIUM COLONY; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; INCUBATION TIME; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ACINETOBACTER; BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 40549099009     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01940.x     Document Type: Article

References (32)

1. Coulson AF Microbiology: proteins that bind the beta-lactam antibiotics Nature 309 1984 668
2. Dofferhoff AS Buijs J The influence of antibiotic-induced filament formation on the release of endotoxin from Gram-negative bacteria J Endotox Res 3 1996 187 194
3. Buijs J Dofferhoff AS Mouton JW van der Meer JW Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice Clin Microbiol Infect 12 2006 1105 1111
4. Held TK Adamczik C Trautmann M Cross AS Effects of MICs and sub-MICs of antibiotics on production of capsular polysaccharide of Klebsiella pneumoniae Antimicrob Agents Chemother 39 1995 1093 1096
5. Nanninga N Morphogenesis of Escherichia coli Microbiol Mol Biol Rev 62 1998 110 129
6. Shenep JL Flynn PM Barrett FF Stidham GL Westenkircher DF Effects of different types and combinations of antimicrobial agents on endotoxin release from Gram-negative bacteria: an in-vitro and in-vivo study Scand J Infect Dis 23 1988 745 754
7. Casey LC Balk RA Bone RC Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome Ann Intern Med 119 1993 771 778
8. Leeson MC Fujihara Y Morrison DC Evidence for lipopolysaccharide as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria Infect Immun 62 1994 4975 4980
9. Kirikae T Nakano M Morrison DC Antibiotic-induced endotoxin release from bacteria and its clinical significance Microbiol Immunol 41 1997 285 294
10. Morrison DC Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis Prog Clin Biol Res 397 1998 199 207
11. Dofferhoff AS Potthoff H Bom VJ The release of endotoxin, TNF and IL-6 during the antibiotic treatment of experimental gram-negative sepsis J Endotox Res 2 1995 37 44
12. Roll JT Young KM Czuprynski CJ Human rTNF-alpha augments anti-bacterial resistance in mice: potentation of its effects by recombinant human rIL-1-alpha Immunology 69 1990 316 322
13. Norimatsu M Morrison DC Correlation of antibiotic-induced endotoxin release and cytokine production in E. coli inoculated mouse whole blood ex-vivo J Infect Dis 177 1998 1302 1307
14. Prins JM van Deventer SJ Kuijper EJ Speelman P Clinical relevance of antibiotic-induced endotoxin release Antimicrob Agents Chemother 38 1994 1211 1218
15. Netea MG van der Meer JW van Deuren M Kullberg BJ Proinflammatory cytokines and sepsis syndrome: not enough or too much of a good thing? Trends Immunol 24 2003 254 258
16. Chen K Sun GW Chua KL Gan YH Modified virulence of antibiotic-induced Burkholderia pseudomallei filaments Antimicrob Agents Chemother 49 2005 1002 1009
17. Turcotte A Simard M Morin NJ Beachamp D Bergeron MG Differential distributions in tissues and efficacies of aztreonam and ceftazidime and in vivo bacterial morphological changes following treatment Antimicrob Agents Chemother 41 1997 401 409
18. van Langevelde P Kwappenberg KM Groeneveld PH Mattie H van Dissel JT Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi : delay between killing by ceftazidime and imipenem and release of LPS Antimicrob Agents Chemother 42 1998 739 743
19. Wientjes FB Nanninga N On the role of the high molecular weight penicillin-binding proteins in the cell cycle of Escherichia coli Res Microbiol 142 1991 333 344
20. Buijs J Dofferhoff AS Mouton JW van der Meer JW Continuous administration of PBP-2 and PBP-3 specific β-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis J Antimicrob Chemother 59 2007 926 933
21. Paterson DL Resistance in gram-negative bacteria: Enterobacteriaceae Am J Infect Control 35 2006 S20 S28
22. Arda B Sipahi OR Yamezhan T Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance J Infect 55 2007 41 48
23. Ho PL Poon WW Loke SL Community emergence of CTX-M type extended-spectrum β-lactamases among urinary Escherichia coli from women J Antimicrob Chemother 60 2007 140 144
24. Nyberg S Osterblad M Hakanen AJ Huovinen P Jalava J Resistance TF Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002–2004 Scand J Infect Dis 39 2007 417 424
25. Brink A Moolman J da Silva MC Botha M Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa S Afr Med J 97 2007 273 279
26. Zahar JR Lecuit M Carbonelle E Ribadeau-Dumas F Nassif X Lortholary O Is it time to reconsider initial antibiotic treatment strategies for severe urinary tract infections in Europe? Clin Microbiol Infect 13 2007 219 221
27. Livermore DM Williams JD The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter Trends Microbiol 14 2006 413 420
28. Babic M Hujer AM Bonom RA What's new in antibiotic resistance? Focus on β-lactamases Drug Resist Update 9 2006 142 156
29. Nakamura T Takahashi H Screening of antibiotic resistance to Enterobacteriaceae, Pseudomonas aeruginosa , and Acinetobacter baumannii by an advanced expert system J Infect Chemother 11 2005 288 292
30. Jackson JJ Kropp H β-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP-3-specific ceftazidime J Infect Dis 165 1992 1033 1041
31. Jackson JJ Kropp H Differences in mode of action of beta-lactam antibiotics, influence on morphology, LPS release and in-vivo antibiotic efficacy J Endotox Res 3 1996 201 218
32. Gould IM MacKenzie FM The response of Enterobacteriaceae to beta-lactam antibiotics–‘round forms, filaments and the root of all evil’ J Antimicrob Chemother 40 1997 495 499